Predictive Value Of Anti Cyclic Citrullinated Peptide and Rheumatoid Factor To The Development Of Rheumatoid Arthritis In a Cohort Of Healthy Relatives Of Patients With Rheumatoid Arthritis.

被引：0
|
作者：
Castillo-Ortiz, Jose Dionisio [1 ]
Ramos-Remus, Cesar [2 ]
机构：
[1] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[2] Unidad Invest Enfermedades Cronicodegenerat, Guadalajara, Jalisco, Mexico
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
357
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [31] Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients
    Sulaiman, Farah Nadiah
    Wong, Kah Keng
    Ahmad, Wan Aireene Wan
    Ghazali, Wan Syamimee Wan
    MEDICINE, 2019, 98 (12)
  • [32] Intermetatarsal bursitis is frequent in patients with established rheumatoid arthritis and is associated with anti-cyclic citrullinated peptide and rheumatoid factor
    Hammer, Hilde Berner
    Kvien, Tore K.
    Terslev, L.
    RMD OPEN, 2019, 5 (02):
  • [33] The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis
    van Jaarsveld, CHM
    ter Borg, EJ
    Jacobs, JWG
    Schellekens, GA
    Gmelig-Meyling, FHJ
    van Booma-Frankfort, C
    de Jong, BAW
    van Venrooij, WJ
    Bijlsma, JWJ
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : 689 - 697
  • [34] Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis
    Vallbracht, I
    Helmke, K
    AUTOIMMUNITY REVIEWS, 2005, 4 (06) : 389 - 394
  • [35] Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
    Ioannis Alexiou
    Anastasios Germenis
    Athanasios Ziogas
    Katerina Theodoridou
    Lazaros I Sakkas
    BMC Musculoskeletal Disorders, 8
  • [36] Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
    Alexiou, Ioannis
    Germenis, Anastasios
    Ziogas, Athanasios
    Theodoridou, Katerina
    Sakkas, Lazaros I.
    BMC MUSCULOSKELETAL DISORDERS, 2007, 8
  • [37] Diagnostic value of antibodies against a modified citrullinated vimentin, cyclic citrullinated peptide and IgM rheumatoid factor in early rheumatoid arthritis
    Novikov, A. A.
    Alexandrova, E. N.
    Karateev, D. E.
    Demidova, N. V.
    Cherkasova, M. V.
    Denisov, L. N.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 333 - 333
  • [38] Predictive value of ACR core set parameters for the development of rheumatoid arthritis in patients with positive anti-cyclic citrullinated peptide antibodies and undifferentiated arthritis
    de Bellefon, Laurent Meric
    Houssiau, Frederic
    Depresseux, Genevieve
    Toukap, Adrien Nzeusseu
    Lauwerys, Bernard
    Durez, Patrick
    RHEUMATOLOGY, 2014, 53 (07) : 1347 - 1348
  • [39] Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and comorbidity
    Stamenkovic, Doris
    Stiglic-Rogoznica, Nives
    Stiglic, Mirna
    Avancini-Dobrovic, Viviana
    Grubisic-Karavanic, Vlasta
    Frlan-Vrgoe, Ljubinka
    Radovic, Endi
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 706 - 707
  • [40] Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritis
    Mikuls, Ted R.
    Holers, V. Michael
    Parrish, Lezlie
    Kuhn, Kristine A.
    Conn, Doyt L.
    Gilkeson, Gary
    Smith, Edwin A.
    Kamen, Diane L.
    Jonas, Beth L.
    Callahan, Leigh F.
    Alarcon, Graciela S.
    Howard, George
    Moreland, Larry W.
    Bridges, S. Louis, Jr.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : 3057 - 3059
12345